3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
11
Phase 1/2
2
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Glioblastoma
107
Gliosarcoma
48
Glioma
41
Brain Neoplasms
38
Astrocytoma
38
Central Nervous System Neoplasms
30
Oligodendroglioma
27
Medulloblastoma
15
Melanoma
14
Neuroblastoma
13
Ependymoma
11
Neoplasms
10
Familial ependymoma
8
Choroid Plexus Neoplasms
8
Unspecified Adult Solid Tumor, Protocol Specific
6
Sarcoma
6
Optic Nerve Glioma
6
Neuroectodermal Tumors, Primitive
6
Neoplasm Metastasis
6
Sarcoma, Ewing
5
Recurrence
5
Rhabdoid Tumor
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Osteosarcoma
4
Lymphoma
4
Glioma, Subependymal
4
Spinal Cord Neoplasms
3
Rhabdomyosarcoma
3
Pinealoma
3
Interventions
Radiotherapy
38
Carboplatin
37
pembrolizumab
36
Cisplatin
34
Paclitaxel
26
Pemetrexed
24
Docetaxel
18
Nivolumab
17
Gemcitabine
17
Bevacizumab
17
Specimen Handling
16
Magnetic Resonance Spectroscopy
16
Cyclophosphamide
15
osimertinib
14
Irinotecan
13
Etoposide
13
Radiation
12
Erlotinib Hydrochloride
12
durvalumab
11
Topotecan
10
Cetuximab
10
Radiosurgery
8
Immunoglobulin G
8
Fluorouracil
8
Everolimus
8
Disulfides
8
Celecoxib
8
fludarabine
7
Taxes
7
Ipilimumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Lung Neoplasms
×
Temozolomide
×
Clear all
NCT00629187
2012-04-27
CN-306
Tufts Medical Center
Phase 1
Terminated
2 enrolled